|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from Operating Activities | |||||
| Net loss | |||||
| Adjustment to reconcile net loss to cash used in operating activities: | |||||
| Change in fair value of convertible promissory notes | |||||
| Change in fair value of earn-out liabilities | |||||
| Amortization of right-of-use assets | |||||
| Change in fair value of warrant liabilities | |||||
| Share-based compensation | |||||
| Realized gain on short term investment | |||||
| Amortization of step-up in loans held for investment | |||||
| Provision for credit losses on loans held for investment | |||||
| Origination of loans and leases for resale | |||||
| Proceeds from sale of loans and leases for resale | |||||
| Gain on sale of loans and leases | |||||
| Impairment of lease merchandise | |||||
| Impairment of software capitalization | |||||
| Depreciation and amortization | |||||
| Non-cash operating lease expense | |||||
| Interest expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Lease receivable | |||||
| Interest receivable | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Deposits | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from Investing Activities | |||||
| Additions to lease merchandise, net of disposals | |||||
| Software development costs | |||||
| Principal paydowns on loans held for investment | |||||
| Disbursements for loans held for investment | |||||
| Purchase of licenses | |||||
| License | |||||
| Total purchase of licenses | |||||
| Purchases of property and equipment | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Purchases of short-term investments | |||||
| Proceeds from the sale of short-term investments | |||||
| Net cash used in investing activities | |||||
| Cash flows from Financing Activities | |||||
| Proceeds from convertible note payable, related party (Note 12) | |||||
| Proceeds from convertible note payable | |||||
| Net proceeds from reverse recapitalization | |||||
| Net disbursements for taxes paid related to vesting of employee restricted stock units | |||||
| Proceeds from issuances of common stock and pre-funded warrants, net | |||||
| Proceeds from issuances of common stock, net of issuance costs | |||||
| Proceeds from revolving line of credit | |||||
| Repayments on revolving line of credit | |||||
| Repayment of subscription payable | |||||
| Cash paid for stock issuance costs | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of the period | |||||
| Supplemental Cash Flow Information | |||||
| Recording of right of use asset and lease liability | |||||
| Promissory notes, inclusive of accrued interest converted to equity | |||||
| Initial recognition of earn-out liability | |||||
| Acquisition of warrant liability | |||||
| Prepaid expenses assumed in connection with Business Combination | |||||
| Liabilities assumed in connection with Business Combination | |||||
| Liabilities paid through the trust | |||||
| Cash paid for interest for convertible notes and revolving line of credit | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Issuance of common shares in connection with the asset acquisition | |||||
| Earnout liability generated by asset acquisition | |||||
| Operating lease right-of-use asset obtained in exchange for operating lease liability | |||||
| Accrued variable compensation settled with RSU grants | |||||
| Shares issued in connection with Credova Merger | |||||
| Note Exchange in connection with Credova Merger | |||||
| Stock for stock transfer | |||||
| Cash and cash equivalents from continuing operations | |||||
| Restricted cash from continuing operations | |||||
| Cash and cash equivalents from discontinued operations | |||||
Loading...